Connection

Saleh Khalil to Cytochrome P-450 CYP3A Inhibitors

This is a "connection" page, showing publications Saleh Khalil has written about Cytochrome P-450 CYP3A Inhibitors.
  1. Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC-MS-Based Metabolomic Approaches. Chem Res Toxicol. 2023 08 21; 36(8):1427-1438.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.